{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:33:38Z","timestamp":1778070818664,"version":"3.51.4"},"reference-count":208,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100010842","name":"Temple University","doi-asserted-by":"publisher","award":["seed grant"],"award-info":[{"award-number":["seed grant"]}],"id":[{"id":"10.13039\/100010842","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11481-019-09878-7","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T19:02:48Z","timestamp":1568228568000},"page":"578-594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A Broad Application of CRISPR Cas9 in Infectious Diseases of Central Nervous System"],"prefix":"10.1007","volume":"14","author":[{"given":"Anna","family":"Bellizzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Ahye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gauthami","family":"Jalagadugula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassen S.","family":"Wollebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,11]]},"reference":[{"key":"9878_CR1","doi-asserted-by":"publisher","first-page":"aaf5573","DOI":"10.1126\/science.aaf5573","volume":"353","author":"OO Abudayyeh","year":"2016","unstructured":"Abudayyeh OO, Gootenberg JS, Konermann S, Joung J, Slaymaker IM, Cox DB, Shmakov S, Makarova KS, Semenova E, Minakhin L, Severinov K, Regev A, Lander ES, Koonin EV, Zhang F (2016) C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science 353:aaf5573. \nhttps:\/\/doi.org\/10.1126\/science.aaf5573","journal-title":"Science"},{"key":"9878_CR2","doi-asserted-by":"publisher","first-page":"26912","DOI":"10.1038\/srep26912","volume":"6","author":"Z Ali","year":"2016","unstructured":"Ali Z, Ali S, Tashkandi M, Zaidi SS, Mahfouz MM (2016) CRISPR\/Cas9-mediated immunity to geminiviruses: differential interference and evasion. Sci Rep 6:26912. \nhttps:\/\/doi.org\/10.1038\/srep26912","journal-title":"Sci Rep"},{"key":"9878_CR3","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1099\/vir.0.19110-0","volume":"84","author":"JB Alimonti","year":"2003","unstructured":"Alimonti JB, Ball TB, Fowke KR (2003) Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J Gen Virol 84:1649\u20131661","journal-title":"J Gen Virol"},{"issue":"7408","key":"9878_CR4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature11286","volume":"487","author":"N. M. Archin","year":"2012","unstructured":"Archin NM, Liberty AL, Kashuba AD, Choudhary SK, Kuruc JD, Crooks AM. ... Richman DD (2012) Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature 487(7408): 482","journal-title":"Nature"},{"key":"9878_CR5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0714.2007.00586.x","volume":"37","author":"PG Arduino","year":"2008","unstructured":"Arduino PG, Porter SR (2008) Herpes simplex virus type 1 infection: overview on relevant clinico-pathological features. J Oral Pathol Med 37:107\u2013121","journal-title":"J Oral Pathol Med"},{"key":"9878_CR6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3449","volume":"13","author":"A Arzumanyan","year":"2013","unstructured":"Arzumanyan A, Reis HM, Feitelson MA (2013) Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma. Nat Rev Cancer 13:123\u2013135","journal-title":"Nat Rev Cancer"},{"key":"9878_CR7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6061\/clinics\/2015(07)09","volume":"70","author":"LS Azevedo","year":"2015","unstructured":"Azevedo LS, Pierrotti LC, Abdala E, Costa SF, Strabelli TM, Campos SV, Ramos JF, Latif AZ, Litvinov N, Maluf NZ, Caiaffa Filho HH, Pannuti CS, Lopes MH, Santos VA, Linardi Cda C, Yasuda MA, Marques HH (2015) Cytomegalovirus infection in transplant recipients. Clinics (Sao Paulo) 70:515\u2013523","journal-title":"Clinics (Sao Paulo)"},{"key":"9878_CR8","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1038\/s41467-018-05157-w","volume":"9","author":"R Badia","year":"2018","unstructured":"Badia R, Ballana E, Castellv\u00ed M, Garc\u00eda-Vidal E, Pujantell M, Clotet B, Prado JG, Puig J, Mart\u00ednez MA, Riveira-Mu\u00f1oz E, Est\u00e9 JA (2018) CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir. Nat Commun 9:2739. \nhttps:\/\/doi.org\/10.1038\/s41467-018-05157-w","journal-title":"Nat Commun"},{"key":"9878_CR9","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.tig.2018.05.004","volume":"34","author":"RO Bak","year":"2018","unstructured":"Bak RO, Gomez-Ospina N, Porteus MH (2018) Gene editing on center stage. Trends Genet 34:600\u2013611","journal-title":"Trends Genet"},{"key":"9878_CR10","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nbt.3659","volume":"34","author":"R Barrangou","year":"2016","unstructured":"Barrangou R, Doudna JA (2016) Applications of CRISPR technologies in research and beyond. Nat Biotechnol 34:933\u2013941","journal-title":"Nat Biotechnol"},{"key":"9878_CR11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.15171\/apb.2018.067","volume":"8","author":"H Bayat","year":"2018","unstructured":"Bayat H, Naderi F, Khan AH, Memarnejadian A, Rahimpour A (2018) The impact of CRISPR-Cas system on antiviral therapy. Adv Pharm Bull 8:591\u2013597","journal-title":"Adv Pharm Bull"},{"issue":"9","key":"9878_CR12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2217\/fvl.12.81","volume":"7","author":"EL Bearer","year":"2012","unstructured":"Bearer EL (2012) HSV, axonal transport and Alzheimer\u2019s disease: in vitro and in vivo evidence for causal relationships. Futur Virol 7(9):885\u2013899","journal-title":"Futur Virol"},{"key":"9878_CR13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.omtn.2018.05.021","volume":"12","author":"Ramona Bella","year":"2018","unstructured":"Bella R, Kaminski R, Mancuso P, Young WB, Chen C, Sariyer R ... Kashanchi F (2018) Removal of HIV DNA by CRISPR from patient blood engrafts in humanized mice. Mol Ther-Nucleic Acids 12: 275\u2013282","journal-title":"Molecular Therapy - Nucleic Acids"},{"issue":"6","key":"9878_CR14","doi-asserted-by":"crossref","first-page":"e0158294","DOI":"10.1371\/journal.pone.0158294","volume":"11","author":"JK Bialek","year":"2016","unstructured":"Bialek JK, Dunay GA, Voges M, Sch\u00e4fer C, Spohn M, Stucka R et al (2016) Targeted HIV-1 latency reversal using CRISPR\/Cas9-derived transcriptional activator systems. PLoS One 11(6):e0158294","journal-title":"PLoS One"},{"key":"9878_CR15","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.1073\/pnas.83.22.8769","volume":"83","author":"KK Biron","year":"1986","unstructured":"Biron KK, Fyfe JA, Stanat SC, Leslie LK, Sorrell JB, Lambe CU, Coen DM (1986) A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl) ethoxy] methyl) guanine (BW B759U) induces reduced levels of BW B759U triphosphate. Proc Natl Acad Sci U S A 83:8769\u20138773","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"9878_CR16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2013.01.006","volume":"98","author":"TM Block","year":"2013","unstructured":"Block TM, Gish R, Guo H, Mehta A, Cuconati A, London WT, Guo JT (2013) Chronic hepatitis B: what should be the goal for new therapies? Antivir Res 98(1):27\u201334","journal-title":"Antivir Res"},{"issue":"4","key":"9878_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/genes9040207","volume":"9","author":"Kristie Bloom","year":"2018","unstructured":"Bloom K, Maepa MB, Ely A, Arbuthnot P: Gene therapy for chronic HBV- can we eliminate cccDNA? Genes (Basel) 9:piiE207. \nhttps:\/\/doi.org\/10.3390\/genes9040207","journal-title":"Genes"},{"issue":"52","key":"9878_CR18","doi-asserted-by":"crossref","first-page":"E7249","DOI":"10.1073\/pnas.1516305112","volume":"112","author":"HP Bogerd","year":"2015","unstructured":"Bogerd HP, Kornepati AV, Marshall JB, Kennedy EM, Cullen BR (2015) Specific induction of endogenous viral restriction factors using CRISPR\/Cas-derived transcriptional activators. Proc Natl Acad Sci 112(52):E7249\u2013E7256","journal-title":"Proc Natl Acad Sci"},{"issue":"13","key":"9878_CR19","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.1093\/nar\/gky571","volume":"46","author":"Y Bollen","year":"2018","unstructured":"Bollen Y, Post J, Koo BK, Snippert HJ (2018) How to create state-of-the-art genetic model systems: strategies for optimal CRISPR-mediated genome editing. Nucleic Acids Res 46(13):6435\u20136454","journal-title":"Nucleic Acids Res"},{"key":"9878_CR20","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1099\/mic.0.28048-0","volume":"151","author":"A Bolotin","year":"2005","unstructured":"Bolotin A, Quinquis B, Sorokin A, Ehrlich SD (2005) Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology 151:2551\u20132561","journal-title":"Microbiology"},{"key":"9878_CR21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1073\/pnas.1523918113","volume":"113","author":"KJ Carroll","year":"2016","unstructured":"Carroll KJ, Makarewich CA, McAnally J, Anderson DM, Zentilin L, Liu N, Giacca M, Bassel-Duby R, Olson EN (2016) A mouse model for adult cardiac-specific gene deletion with CRISPR\/Cas9. Proc Natl Acad Sci U S A 113:338\u2013343","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9878_CR22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nbt.4066","volume":"36","author":"A Casini","year":"2018","unstructured":"Casini A, Olivieri M, Petris G, Montagna C, Reginato G, Maule G, Lorenzin F, Prandi D, Romanel A, Demichelis F, Inga A, Cereseto A (2018) A highly specific SpCas9 variant is identified by in vivo screening in yeast. Nat Biotechnol 36:265\u2013271","journal-title":"Nat Biotechnol"},{"key":"9878_CR23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.antiviral.2015.07.006","volume":"121","author":"J Chang","year":"2015","unstructured":"Chang J, Guo JT (2015) Treatment of chronic hepatitis B with pattern recognition receptor agonists: current status and potential for a cure. Antivir Res 121:152\u2013159","journal-title":"Antivir Res"},{"key":"9878_CR24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","volume":"25","author":"CT Charlesworth","year":"2019","unstructured":"Charlesworth CT, Deshpande PS, Dever DP, Camarena J, Lemgart VT, Cromer MK, Vakulskas CA, Collingwood MA, Zhang L, Bode NM, Behlke MA, Dejene B, Cieniewicz B, Romano R, Lesch BJ, Gomez-Ospina N, Mantri S, Pavel-Dinu M, Weinberg KI, Porteus MH (2019) Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nat Med 25:249\u2013254","journal-title":"Nat Med"},{"issue":"32","key":"9878_CR25","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","volume":"29","author":"AK Chaturvedi","year":"2011","unstructured":"Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294","journal-title":"J Clin Oncol"},{"key":"9878_CR26","doi-asserted-by":"crossref","first-page":"14457","DOI":"10.1074\/jbc.M116.733154","volume":"291","author":"S Chen","year":"2016","unstructured":"Chen S, Lee B, Lee AY, Modzelewski AJ, He L (2016) Highly efficient mouse genome editing by CRISPR ribonucleoprotein electroporation of zygotes. J Biol Chem 291:14457\u201314467","journal-title":"J Biol Chem"},{"key":"9878_CR27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature24268","volume":"550","author":"JS Chen","year":"2017","unstructured":"Chen JS, Dagdas YS, Kleinstiver BP, Welch MM, Sousa AA, Harrington LB, Sternberg SH, Joung JK, Yildiz A, Doudna JA (2017) Enhanced proofreading governs CRISPR\u2013Cas9 targeting accuracy. Nature 550:407\u2013410","journal-title":"Nature"},{"key":"9878_CR28","doi-asserted-by":"publisher","first-page":"piiE291","DOI":"10.3390\/v10060291","volume":"10","author":"YC Chen","year":"2018","unstructured":"Chen YC, Sheng J, Trang P, Liu F (2018) Potential application of the CRISPR\/Cas9 system against herpesvirus infections. Viruses 10:piiE291. \nhttps:\/\/doi.org\/10.3390\/v10060291","journal-title":"Viruses"},{"key":"9878_CR29","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1016\/j.febslet.2014.09.008","volume":"588","author":"R Cheng","year":"2014","unstructured":"Cheng R, Peng J, Yan Y, Cao P, Wang J, Qiu C, Tang L, Liu D, Tang L, Jin J, Huang X, He F, Zhang P (2014) Highly efficient gene editing in adult mouse livers via adenoviral delivery of CRISPR\/Cas9. FEBS Lett 588:3954\u20133958","journal-title":"FEBS Lett"},{"issue":"8","key":"9878_CR30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm.1972","volume":"15","author":"N Chomont","year":"2009","unstructured":"Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, Yassine-Diab B, Schacker TW (2009) HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 15(8):893","journal-title":"Nat Med"},{"key":"9878_CR31","doi-asserted-by":"publisher","first-page":"36921","DOI":"10.1038\/srep36921","volume":"6","author":"YY Chou","year":"2016","unstructured":"Chou YY, Krupp A, Kaynor C, Gaudin R, Ma M, Cahir-McFarland E, Kirchhausen T (2016) Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR\/Cas9. Sci Rep 6:36921. \nhttps:\/\/doi.org\/10.1038\/srep36921","journal-title":"Sci Rep"},{"key":"9878_CR32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nbt.3198","volume":"33","author":"VT Chu","year":"2015","unstructured":"Chu VT, Weber T, Wefers B, Wurst W, Sander S, Rajewsky K, K\u00fchn R (2015) Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nat Biotechnol 33:543\u2013548","journal-title":"Nat Biotechnol"},{"key":"9878_CR33","doi-asserted-by":"publisher","first-page":"107fs7","DOI":"10.1126\/scitranslmed.3002878","volume":"3","author":"JI Cohen","year":"2011","unstructured":"Cohen JI, Fauci AS, Varmus H, Nabel GJ (2011) Epstein Barr virus: an important vaccine target for cancer preventation. Sci Transl Med 3:107fs7. \nhttps:\/\/doi.org\/10.1126\/scitranslmed.3002878","journal-title":"Sci Transl Med"},{"key":"9878_CR34","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41591-018-0026-6","volume":"24","author":"DJ Colby","year":"2018","unstructured":"Colby DJ, Trautmann L, Pinyakorn S, Leyre L, Pagliuzza A, Kroon E et al (2018) Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection. Nat Med 24:923\u2013926","journal-title":"Nat Med"},{"issue":"1","key":"9878_CR35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.uct.2008.01.001","volume":"3","author":"J Craddock","year":"2008","unstructured":"Craddock J, Heslop HE (2008) Adoptive cellular therapy with T cells specific for EBV-derived tumor antigens. Update Cancer Ther 3(1):33\u201341","journal-title":"Update Cancer Ther"},{"key":"9878_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136690","volume":"10","author":"M Crispo","year":"2015","unstructured":"Crispo M, Mulet AP, Tesson L, Barrera N, Cuadro F, dos Santos-Neto PC, Nguyen TH, Cr\u00e9n\u00e9guy A, Brusselle L, Aneg\u00f3n I, Menchaca A (2015) Efficient generation of myostatin knock-out sheep using CRISPR\/Cas9 technology and microinjection into zygotes. PLoS One 10:e0136690. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0136690","journal-title":"PLoS One"},{"key":"9878_CR37","first-page":"211","volume":"16","author":"Y D'Agostino","year":"2017","unstructured":"D'Agostino Y, D'Aniello S (2017) Molecular basis, applications and challenges of CRISPR\/Cas9: a continuously evolving tool for genome editing. Brief Funct Genomics 16:211\u2013216","journal-title":"Brief Funct Genomics"},{"key":"9878_CR38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1552-6909.2002.tb00026.x","volume":"31","author":"EG Damato","year":"2002","unstructured":"Damato EG, Winnen CW (2002) Cytomegalovirus infection: perinatal implications. J Obstet Gynecol Neonatal Nurs 31:86\u201392","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"issue":"suppl_4","key":"9878_CR39","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.1093\/cid\/ciw023","volume":"62","author":"M Dandri","year":"2016","unstructured":"Dandri M, Petersen J (2016) Mechanism of hepatitis B virus persistence in hepatocytes and its carcinogenic potential. Clin Infect Dis 62(suppl_4):S281\u2013S288","journal-title":"Clin Infect Dis"},{"issue":"4","key":"9878_CR40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/v10040157","volume":"10","author":"G Darcis","year":"2018","unstructured":"Darcis G, Das A, Berkhout B (2018) Tackling HIV persistence: pharmacological versus CRISPR-based shock strategies. Viruses 10(4):157","journal-title":"Viruses"},{"key":"9878_CR41","doi-asserted-by":"publisher","unstructured":"Dash PK, Kaminski R, Bella R, Hang S, Mathews S, Ahooyi TM, Chen C, Mancuso P, Sariyer R, Ferrante P, Donadoni M, Robinson JA, Sillman B, Lin Z, Hilaire JR, Banoub M, Elango M, Gautam N, Mosely RL, Poluektova LY, McMillan J, Bade AN, Gorantla S, Sariyer IK, Burdo TH, Young WB, Amini S, Gordon J, Jacobson JM, Edagwa B, Khalili K, Gendelman HE (2019) Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice. Nat Commun. \nhttps:\/\/doi.org\/10.2753\/\/doi.org\/10.1038\/s41467-019-10366-y","DOI":"10.2753\/\/doi.org\/10.1038\/s41467-019-10366-y"},{"key":"9878_CR42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/1570162X14666160324125536","volume":"14","author":"PK Datta","year":"2016","unstructured":"Datta PK, Kaminiski R, Hu W, Pirrone V, Sullivan NT, Nonnemacher MR, Dampier W, Wigdahl B, Khalili K (2016) HIV-1 latency and eradication: past, present and future. Curr HIV Res 14:431\u2013441","journal-title":"Curr HIV Res"},{"issue":"8","key":"9878_CR43","first-page":"e02209","volume":"93","author":"JR Doll","year":"2019","unstructured":"Doll JR, Thompson RL, Sawtell NM (2019) Infectious herpes simplex virus in the brain stem is correlated with reactivation in the trigeminal ganglia. J Virol 93(8):e02209\u2013e02218","journal-title":"J Virol"},{"key":"9878_CR44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2015.03.015","volume":"118","author":"C Dong","year":"2015","unstructured":"Dong C, Qu L, Wang H, Wei L, Dong Y, Xiong S (2015) Targeting hepatitis B virus cccDNA by CRISPR\/Cas9 nuclease efficiently inhibits viral replication. Antivir Res 118:110\u2013117","journal-title":"Antivir Res"},{"issue":"Supplement_3","key":"9878_CR45","doi-asserted-by":"crossref","first-page":"S468","DOI":"10.1093\/clinids\/10.Supplement_3.S468","volume":"10","author":"WL Drew","year":"1988","unstructured":"Drew WL (1988) Diagnosis of cytomegalovirus infection. Rev Infect Dis 10(Supplement_3):S468\u2013S476","journal-title":"Rev Infect Dis"},{"issue":"1","key":"9878_CR46","doi-asserted-by":"crossref","first-page":"e0191709","DOI":"10.1371\/journal.pone.0191709","volume":"13","author":"Caroline Dufour","year":"2018","unstructured":"Dufour, C., Claudel, A., Joubarne, N., Merindol, N., Maisonnet, T., Masroori, N., ... Berthoux, L. (2018). Editing of the human TRIM5 gene to introduce mutations with the potential to inhibit HIV-1. PLoS One 13(1):e0191709","journal-title":"PLOS ONE"},{"key":"9878_CR47","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1038\/srep02510","volume":"3","author":"H Ebina","year":"2013","unstructured":"Ebina H, Misawa N, Kanemura Y, Koyanagi Y (2013) Harnessing the CRISPR\/Cas9 system to disrupt latent HIV-1 provirus. Sci Rep 3:2510. \nhttps:\/\/doi.org\/10.1038\/srep02510","journal-title":"Sci Rep"},{"key":"9878_CR48","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein MA (1964) Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1:702\u2013703","journal-title":"Lancet"},{"key":"9878_CR49","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nature13695","volume":"513","author":"GM Findlay","year":"2014","unstructured":"Findlay GM, Boyle EA, Hause RJ, Klein JC, Shendure J (2014) Saturation editing of genomic regions by multiplex homology-directed repair. Nature 513:120\u2013123","journal-title":"Nature"},{"issue":"5","key":"9878_CR50","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/8394","volume":"5","author":"Diana Finzi","year":"1999","unstructured":"Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, ... Quinn TC (1999) Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 5(5): 512","journal-title":"Nature Medicine"},{"issue":"2","key":"9878_CR51","first-page":"682-693.e4","volume":"138","author":"Paola Fisicaro","year":"2010","unstructured":"Fisicaro P, Valdatta C, Massari M, Loggi E, Biasini E, Sacchelli L, ... Ferrari C (2010). Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 138(2): 682\u2013693","journal-title":"Gastroenterology"},{"key":"9878_CR52","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","volume":"31","author":"Y Fu","year":"2013","unstructured":"Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD (2013) High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31:822\u2013826","journal-title":"Nat Biotechnol"},{"key":"9878_CR53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/liv.13304","volume":"37","author":"EJ Gane","year":"2016","unstructured":"Gane EJ (2016) Future anti-HBV strategies. Liver Int 37:40\u201344","journal-title":"Liver Int"},{"key":"9878_CR54","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR (2017) Programmable base editing of a\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature 551:464\u2013471","journal-title":"Nature"},{"issue":"2","key":"9878_CR55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192602","volume":"13","author":"J Gergen","year":"2018","unstructured":"Gergen J, Coulon F, Creneguy A, Elain-Duret N, Gutierrez A, Pinkenburg O, Haspot F (2018) Multiplex CRISPR\/Cas9 system impairs HCMV replication by excising an essential viral gene. PLoS One 13(2):e0192602","journal-title":"PLoS One"},{"key":"9878_CR56","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","volume":"159","author":"LA Gilbert","year":"2014","unstructured":"Gilbert LA, Horlbeck MA, Adamson B, Villalta JE, Chen Y, Whitehead EH, Guimaraes C, Panning B, Ploegh HL, Bassik MC, Qi LS, Kampmann M, Weissman JS (2014) Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159:647\u2013661","journal-title":"Cell"},{"issue":"S10","key":"9878_CR57","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/cncr.23764","volume":"113","author":"ML Gillison","year":"2008","unstructured":"Gillison ML, Chaturvedi AK, Lowy DR (2008) HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 113(S10):3036\u20133046","journal-title":"Cancer"},{"key":"9878_CR58","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2174\/1874357901206010198","volume":"6","author":"PE Gravitt","year":"2012","unstructured":"Gravitt PE (2012) Suppl 2: evidence and impact of human papillomavirus latency. Open Virol J 6:198","journal-title":"Open Virol J"},{"key":"9878_CR59","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4149\/av_2017_02_02","volume":"61","author":"JC Green","year":"2017","unstructured":"Green JC, Hu JS (2017) Editing plants for virus resistance using CRISPR-Cas. Acta Virol 61:138\u2013142","journal-title":"Acta Virol"},{"issue":"1","key":"9878_CR60","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.vetmic.2010.02.017","volume":"143","author":"BD Griffin","year":"2010","unstructured":"Griffin BD (2010) Marieke C. Verweij, and Emmanuel JHJ Wiertz. \"herpesviruses and immunity: the art of evasion.\". Vet Microbiol 143(1):89\u2013100","journal-title":"Vet Microbiol"},{"key":"9878_CR61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mrrev.2016.07.002","volume":"2017","author":"ME Harden","year":"2017","unstructured":"Harden ME, Munger K (2017) Human papillomavirus molecular biology. Mutat Res 2017:3\u201312. \nhttps:\/\/doi.org\/10.1016\/j.mrrev.2016.07.002","journal-title":"Mutat Res"},{"key":"9878_CR62","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1042\/BST20160060","volume":"44","author":"E Herrera-Carrillo","year":"2016","unstructured":"Herrera-Carrillo E, Berkhout B (2016) Attacking HIV-1 RNA versus DNA by sequence-specific approaches: RNAi versus CRISPR-Cas. Biochem Soc Trans 44:1355\u20131365","journal-title":"Biochem Soc Trans"},{"key":"9878_CR63","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nbt.3199","volume":"33","author":"IB Hilton","year":"2015","unstructured":"Hilton IB, D'Ippolito AM, Vockley CM, Thakore PI, Crawford GE, Reddy TE, Gersbach CA (2015) Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol 33:510\u2013517","journal-title":"Nat Biotechnol"},{"key":"9878_CR64","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cell.2016.01.039","volume":"164","author":"H Hirano","year":"2016","unstructured":"Hirano H, Gootenberg JS, Horii T, Abudayyeh OO, Kimura M, Hsu PD, Nakane T, Ishitani R, Hatada I, Zhang F, Nishimasu H, Nureki O (2016) Structure and engineering of Francisella novicida Cas9. Cell 164:950\u2013961","journal-title":"Cell"},{"key":"9878_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005102","volume":"11","author":"YK Ho","year":"2015","unstructured":"Ho YK, Zhi H, Bowlin T, Dorjbal B, Philip S, Zahoor MA, Shih HM, Semmes OJ, Schaefer B, Glover JN, Giam CZ (2015) HTLV-1 tax stimulates ubiquitin E3 ligase, ring finger protein 8, to assemble lysine 63-linked polyubiquitin chains for TAK1 and IKK activation. PLoS Pathog 11:e1005102. \nhttps:\/\/doi.org\/10.1371\/journal.ppat.1005102","journal-title":"PLoS Pathog"},{"issue":"1","key":"9878_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00432-005-0036-x","volume":"132","author":"M Hong","year":"2006","unstructured":"Hong M, Murai Y, Kutsuna T, Takahashi H, Nomoto K, Cheng CM, Tsuneyama K (2006) Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt\u2019s lymphoma cells. J Cancer Res Clin Oncol 132(1):1\u20138","journal-title":"J Cancer Res Clin Oncol"},{"key":"9878_CR67","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.1038\/srep04513","volume":"4","author":"T Horii","year":"2014","unstructured":"Horii T, Arai Y, Yamazaki M, Morita S, Kimura M, Itoh M, Abe Y, Hatada I (2014) Validation of microinjection methods for generating knockout mice by CRISPR\/Cas-mediated genome engineering. Sci Rep 4:4513. \nhttps:\/\/doi.org\/10.1038\/srep04513","journal-title":"Sci Rep"},{"key":"9878_CR68","doi-asserted-by":"publisher","first-page":"15577","DOI":"10.1038\/srep15577","volume":"5","author":"P Hou","year":"2015","unstructured":"Hou P, Chen S, Wang S, Yu X, Chen Y, Jiang M, Zhuang K, Ho W, Hou W, Huang J, Guo D (2015) Genome editing of CXCR4 by CRISPR\/cas9 confers cells resistant to HIV-1 infection. Sci Rep 5:15577. \nhttps:\/\/doi.org\/10.1038\/srep15577","journal-title":"Sci Rep"},{"key":"9878_CR69","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, Cradick TJ, Marraffini LA, Bao G, Zhang F (2013) DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31:827\u2013832","journal-title":"Nat Biotechnol"},{"key":"9878_CR70","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"PD Hsu","year":"2014","unstructured":"Hsu PD, Lander ES, Zhang F (2014) Development and applications of CRISPR-Cas9 for genome engineering. Cell 157:1262\u20131278","journal-title":"Cell"},{"key":"9878_CR71","doi-asserted-by":"crossref","first-page":"11461","DOI":"10.1073\/pnas.1405186111","volume":"111","author":"W Hu","year":"2014","unstructured":"Hu W, Kaminski R, Yang F, Zhang Y, Cosentino L, Li F, Luo B, Alvarez-Carbonell D, Garcia-Mesa Y, Karn J, Mo X, Khalili K (2014a) RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. Proc Natl Acad Sci U S A 111:11461\u201311466","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9878_CR72","doi-asserted-by":"publisher","first-page":"612823","DOI":"10.1155\/2014\/612823","volume":"2014","author":"Z Hu","year":"2014","unstructured":"Hu Z, Yu L, Zhu D, Ding W, Wang X, Zhang C, Wang L, Jiang X, Shen H, He D, Li K, Xi L, Ma D, Wang H (2014b) Disruption of HPV16 E7 by crispr\/cas system induces apoptosis and growth inhibition in HPV 16 positive human cervical cancer cells. Biomed Res Int 2014:612823. \nhttps:\/\/doi.org\/10.1155\/2014\/612823","journal-title":"Biomed Res Int"},{"key":"9878_CR73","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1167\/iovs.16-19316","volume":"57","author":"SS Hung","year":"2016","unstructured":"Hung SS, Chrysostomou V, Li F, Lim JK, Wang JH, Powell JE, Tu L, Daniszewski M, Lo C, Wong RC, Crowston JG, P\u00e9bay A, King AE, Bui BV, Liu GS, Hewitt AW (2016) AAV-mediated CRISPR\/Cas gene editing of retinal cells in vivo. Invest Ophthalmol Vis Sci 57:3470\u20133476","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"9878_CR74","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4161\/cbt.7.10.6564","volume":"7","author":"MX Ian","year":"2008","unstructured":"Ian MX, Lan SZ, Cheng ZF, Dan H, Qiong LH (2008) Suppression of EBNA1 expression inhibits growth of EBV positive NK\/T cell lymphomas cells. Cancer Biol Ther 7(10):1602\u20131606","journal-title":"Cancer Biol Ther"},{"issue":"12","key":"9878_CR75","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1128\/JB.169.12.5429-5433.1987","volume":"169","author":"Y Ishino","year":"1987","unstructured":"Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A (1987) Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol 169(12):5429\u20135433","journal-title":"J Bacteriol"},{"key":"9878_CR76","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fnagi.2018.00324","volume":"10","author":"RF Itzhaki","year":"2018","unstructured":"Itzhaki RF (2018) Corroboration of a major role for herpes simplex virus type 1 in Alzheimer's disease. Front Aging Neurosci 10:324","journal-title":"Front Aging Neurosci"},{"key":"9878_CR77","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/cr.2017.16","volume":"27","author":"C Jiang","year":"2017","unstructured":"Jiang C, Mei M, Li B, Zhu X, Zu W, Tian Y, Wang Q, Guo Y, Dong Y, Tan X (2017) A non-viral CRISPR\/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo. Cell Res 27:440\u2013443","journal-title":"Cell Res"},{"key":"9878_CR78","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/gt.2016.45","volume":"23","author":"R Kaminski","year":"2016","unstructured":"Kaminski R, Bella R, Yin C, Otte J, Ferrante P, Gendelman HE, Li H, Booze R, Gordon J, Hu W, Khalili K (2016a) Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study. Gene Ther 23:696. \nhttps:\/\/doi.org\/10.1038\/gt.2016.45","journal-title":"Gene Ther"},{"key":"9878_CR79","doi-asserted-by":"publisher","first-page":"22555","DOI":"10.1038\/srep22555","volume":"6","author":"R Kaminski","year":"2016","unstructured":"Kaminski R, Chen Y, Fischer T, Tedaldi E, Napoli A, Zhang Y, Karn J, Hu W, Khalili K (2016b) Elimination of HIV-1 genomes from human T-lymphoid cells by CRISPR\/Cas9 gene editing. Sci Rep 6:22555. \nhttps:\/\/doi.org\/10.1038\/srep22555","journal-title":"Sci Rep"},{"issue":"9","key":"9878_CR80","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1128\/JVI.00060-16","volume":"90","author":"Teru Kanda","year":"2016","unstructured":"Kanda T, Furuse Y, Oshitani H, Kiyono (2016) Highly efficient crispr\/cas-mediated cloning and functional characterization of gastric cancer-derived epstein-barr virus strains. J Virol 90:4383\u20134393","journal-title":"Journal of Virology"},{"key":"9878_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.42","volume":"4","author":"H Kang","year":"2015","unstructured":"Kang H, Minder P, Park MA, Mesquitta WT, Torbett BE, Slukvin II (2015) CCR5 disruption in induced pluripotent stem cells using CRISPR\/Cas9 provides selective resistance of immune cells to CCR5-tropic HIV-1 virus. Mol Ther Nucleic Acids 4:e268. \nhttps:\/\/doi.org\/10.1038\/mtna.2015.42","journal-title":"Mol Ther Nucleic Acids"},{"key":"9878_CR82","doi-asserted-by":"publisher","first-page":"13734","DOI":"10.1038\/srep13734","volume":"5","author":"M Karimova","year":"2015","unstructured":"Karimova M, Beschorner N, Dammermann W, Chemnitz J, Indenbirken D, Bockmann JH, Grundhoff A, L\u00fcth S, Buchholz F, Schulze zur Wiesch J, Hauber J (2015) CRISPR\/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X. Sci Rep 5:13734. \nhttps:\/\/doi.org\/10.1038\/srep13734","journal-title":"Sci Rep"},{"key":"9878_CR83","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1038\/s41598-019-40222-4","volume":"9","author":"A Kaushik","year":"2019","unstructured":"Kaushik A, Yndart A, Atluri V, Tiwari S, Tomitaka A, Gupta P, Jayant RD, Alvarez-Carbonell D, Khalili K, Nair M (2019) Magnetically guided non-invasive CRISPR-Cas9\/gRNA delivery across blood-brain barrier to eradicate latent HIV-1 infection. Sci Rep 9:3928. \nhttps:\/\/doi.org\/10.1038\/s41598-019-40222-4","journal-title":"Sci Rep"},{"key":"9878_CR84","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.virol.2015.02.024","volume":"479-480","author":"EM Kennedy","year":"2015","unstructured":"Kennedy EM, Cullen BR (2015) Bacterial CRISPR\/Cas DNA endonucleases: a revolutionary technology that could dramatically impact viral research and treatment. Virology 479-480:213\u2013220","journal-title":"Virology"},{"key":"9878_CR85","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-med-051215-031129","volume":"68","author":"EM Kennedy","year":"2017","unstructured":"Kennedy EM, Cullen BR (2017) Gene editing: a new tool for viral disease. Annu Rev Med 68:401\u2013411","journal-title":"Annu Rev Med"},{"key":"9878_CR86","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2014.12.001","volume":"476","author":"EM Kennedy","year":"2015","unstructured":"Kennedy EM, Bassit LC, Mueller H, Kornepati AVR, Bogerd HP, Nie T, Chatterjee P, Javanbakht H, Schinazi RF, Cullen BR (2015) Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR\/Cas RNA-guided DNA endonuclease. Virology 476:196\u2013205","journal-title":"Virology"},{"key":"9878_CR87","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1101\/gr.199588.115","volume":"26","author":"D Kim","year":"2016","unstructured":"Kim D, Kim S, Kim S, Park J, Kim JS (2016) Genome-wide target specificities of CRISPR-Cas9 nucleases revealed by multiplex Digenome-seq. Genome Res 26:406\u2013415","journal-title":"Genome Res"},{"key":"9878_CR88","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","volume":"529","author":"BP Kleinstiver","year":"2016","unstructured":"Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, Joung JK (2016) High-fidelity CRISPR\u2013Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529:490\u2013495","journal-title":"Nature"},{"key":"9878_CR89","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nature14136","volume":"517","author":"S Konermann","year":"2015","unstructured":"Konermann S, Brigham MD, Trevino AE, Joung J, Abudayyeh OO, Barcena C, Hsu PD, Habib N, Gootenberg JS, Nishimasu H, Nureki O, Zhang F (2015) Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517:583\u2013588","journal-title":"Nature"},{"key":"9878_CR90","doi-asserted-by":"publisher","first-page":"1700540","DOI":"10.1002\/advs.201700540","volume":"5","author":"YH Lao","year":"2018","unstructured":"Lao YH, Li M, Gao MA, Shao D, Chi CW, Huang D, Chakraborty S, Ho TC, Jiang W, Wang HX, Wang S, Leong KW (2018) HPV oncogene manipulation using nonvirally delivered crispr\/cas9 or Natronobacterium Gregoryi Argonaute. Adv Sci (Weinh) 5:1700540. \nhttps:\/\/doi.org\/10.1002\/advs.201700540","journal-title":"Adv Sci (Weinh)"},{"key":"9878_CR91","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/15476286.2019.1582974","volume":"16","author":"A Le Rhun","year":"2019","unstructured":"Le Rhun A, Escalera-Maurer A, Bratovi\u010d M, Charpentier E (2019) CRISPR-Cas in Streptococcus Pyogenes. RNA Biol 16:380\u2013389","journal-title":"RNA Biol"},{"key":"9878_CR92","doi-asserted-by":"publisher","first-page":"41968","DOI":"10.1038\/srep41968","volume":"7","author":"RJ Lebbink","year":"2017","unstructured":"Lebbink RJ, De Jong DC, Wolters F, Kruse EM, Van Ham PM, Wiertz EJ, Nijhuis M (2017) A combinational CRISPR\/Cas9 gene-editing approach can halt HIV replication and prevent viral escape. Sci Rep 7:41968. \nhttps:\/\/doi.org\/10.1038\/srep41968","journal-title":"Sci Rep"},{"issue":"7","key":"9878_CR93","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3390\/molecules24071349","volume":"24","author":"C Lee","year":"2019","unstructured":"Lee C (2019) CRISPR\/Cas9-based antiviral strategy: current status and the potential challenge. Molecules 24(7):1349","journal-title":"Molecules"},{"issue":"2","key":"9878_CR94","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0304-3835(00)00353-0","volume":"154","author":"MH Lee","year":"2000","unstructured":"Lee MH, Chiou JF, Yen KY, Yang LL (2000) EBV DNA polymerase inhibition of tannins from Eugenia uniflora. Cancer Lett 154(2):131\u2013136","journal-title":"Cancer Lett"},{"issue":"1","key":"9878_CR95","doi-asserted-by":"crossref","first-page":"208","DOI":"10.21037\/jgo.2017.06.08","volume":"9","author":"S Lee","year":"2018","unstructured":"Lee S, Loecher M, Iyer R (2018) Immunomodulation in hepatocellular cancer. J Gastrointest Oncol 9(1):208","journal-title":"J Gastrointest Oncol"},{"key":"9878_CR96","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1099\/vir.0.000139","volume":"96","author":"C Li","year":"2015","unstructured":"Li C, Guan X, Du T, Jin W, Wu B, Liu Y, Wang P, Hu B, Griffin GE, Shattock RJ, Hu Q (2015) Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR\/Cas9. J Gen Virol 96:2381\u20132393","journal-title":"J Gen Virol"},{"key":"9878_CR97","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fcimb.2017.00091","volume":"7","author":"H Li","year":"2017","unstructured":"Li H, Sheng C, Wang S, Yang L, Liang Y, Huang Y, Liu H, Li P, Yang C, Yang X, Jia L, Xie J, Wang L, Hao R, Du X, Xu D, Zhou J, Li M, Sun Y, Tong Y, Li Q, Qiu S, Song H (2017) Removal of integrated hepatitis B virus DNA using CRISPR-Cas9. Front Cell Infect Microbiol 7:91. \nhttps:\/\/doi.org\/10.3389\/fcimb.2017.00091","journal-title":"Front Cell Infect Microbiol"},{"key":"9878_CR98","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.1038\/ncomms7413","volume":"6","author":"HK Liao","year":"2015","unstructured":"Liao HK, Gu Y, Diaz A, Marlett J, Takahashi Y, Li M, Suzuki K, Xu R, Hishida T, Chang CJ, Esteban CR, Young J, Izpisua Belmonte JC (2015) Use of the CRISPR\/Cas9 system as an intracellular defense against HIV-1 infection in human cells. Nat Commun 6:6413. \nhttps:\/\/doi.org\/10.1038\/ncomms7413","journal-title":"Nat Commun"},{"key":"9878_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2014.38","volume":"3","author":"SR Lin","year":"2014","unstructured":"Lin SR, Yang HC, Kuo YT, Liu CJ, Yang TY, Sung KC, Lin YY, Wang HY, Wang CC, Shen YC, Wu FY, Kao JH, Chen DS, Chen PJ (2014) The CRISPR\/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo. Mol Ther Nucleic Acids 3:e186. \nhttps:\/\/doi.org\/10.1038\/mtna.2014.38","journal-title":"Mol Ther Nucleic Acids"},{"key":"9878_CR100","doi-asserted-by":"publisher","first-page":"34531","DOI":"10.1038\/srep34531","volume":"6","author":"C Lin","year":"2016","unstructured":"Lin C, Li H, Hao M, Xiong D, Luo Y, Huang C, Yuan Q, Zhang J, Xia N (2016) Increasing the efficiency of crispr\/cas9 \u2013mediated precise genome editing of HSV-1 virus in human cels. Sci Rep 6:34531. \nhttps:\/\/doi.org\/10.1038\/srep34531","journal-title":"Sci Rep"},{"key":"9878_CR101","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","volume":"25","author":"CA Lino","year":"2018","unstructured":"Lino CA, Harper JC, Carney JP, Timlin JA (2018) Delivering CRISPR: a review of the challenges and approaches. Drug Deliv 25:1234\u20131257","journal-title":"Drug Deliv"},{"key":"9878_CR102","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jconrel.2017.09.012","volume":"266","author":"C Liu","year":"2017","unstructured":"Liu C, Zhang L, Liu H, Cheng K (2017) Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications. J Control Release 266:17\u201326","journal-title":"J Control Release"},{"key":"9878_CR103","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.antiviral.2018.02.011","volume":"152","author":"Y Liu","year":"2018","unstructured":"Liu Y, Zhao M, Gong M, Xu Y, Xie C, Deng H, Li X, Wu H, Wang Z (2018) Inhibition of hepatitis B virus replication via HBV DNA cleavage by Cas9 from Staphylococcus aureus. Antivir Res 152:58\u201367","journal-title":"Antivir Res"},{"key":"9878_CR104","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","volume":"351","author":"C Long","year":"2016","unstructured":"Long C, Amoasii L, Mireault AA, McAnally JR, Li H, Sanchez-Ortiz E, Bhattacharyya S, Shelton JM, Bassel-Duby R, Olson EN (2016) Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science 351:400\u2013403","journal-title":"Science"},{"issue":"2019","key":"9878_CR105","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cld.2019.04.006","volume":"23","author":"U Lopatin","year":"2019","unstructured":"Lopatin U (2019) Drugs in the pipeline for HBV. Clin Liver Dis 23(2019):535\u2013555","journal-title":"Clin Liver Dis"},{"issue":"9939","key":"9878_CR106","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0140-6736(14)60164-1","volume":"384","author":"G Maartens","year":"2014","unstructured":"Maartens G, Celum C, Lewin SR (2014) HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet 384(9939):258\u2013271","journal-title":"Lancet"},{"key":"9878_CR107","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nature13902","volume":"516","author":"D Maddalo","year":"2014","unstructured":"Maddalo D, Manchado E, Concepcion CP, Bonetti C, Vidigal JA, Han YC, Ogrodowski P, Crippa A, Rekhtman N, De Stanchina E, Lowe SW, Ventura A (2014) In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR\/Cas9 system. Nature 516:423\u2013427","journal-title":"Nature"},{"key":"9878_CR108","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/nar\/gkv1540","volume":"44","author":"I Maggio","year":"2016","unstructured":"Maggio I, Stefanucci L, Janssen JM, Liu J, Chen X, Mouly V, Gon\u00e7alves MA (2016) Selection-free gene repair after adenoviral vector transduction of designer nucleases: rescue of dystrophin synthesis in DMD muscle cell populations. Nucleic Acids Res 44:1449\u20131470","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"9878_CR109","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.virol.2011.03.019","volume":"414","author":"GA Maglennon","year":"2011","unstructured":"Maglennon GA, McIntosh P, Doorbar J (2011) Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression. Virology 414(2):153\u2013163","journal-title":"Virology"},{"key":"9878_CR110","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nbt.2675","volume":"31","author":"P Mali","year":"2013","unstructured":"Mali P, Aach J, Stranges PB, Esvelt KM, Moosburner M, Kosuri S, Yang L, Church GM (2013) CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol 31:833\u2013838","journal-title":"Nat Biotechnol"},{"key":"9878_CR111","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.coviro.2017.12.003","volume":"28","author":"M Manglani","year":"2018","unstructured":"Manglani M, McGavern DB (2018) New advances in CNS immunity against viral infection. Curr Opin Virol 28:116\u2013126","journal-title":"Curr Opin Virol"},{"key":"9878_CR112","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nbt0216-210c","volume":"34","author":"T Maruyama","year":"2015","unstructured":"Maruyama T, Dougan SK, Truttmann MC, Bilate AM, Ingram JR, Ploegh HL (2015) Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat Biotechnol 34:210. \nhttps:\/\/doi.org\/10.1038\/nbt0216-210c","journal-title":"Nat Biotechnol"},{"key":"9878_CR113","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nm.3802","volume":"21","author":"M Matano","year":"2015","unstructured":"Matano M, Date S, Shimokawa M, Takano A, Fujii M, Ohta Y, Watanabe T, Kanai T, Sato T (2015) Modeling colorectal cancer using CRISPR-Cas9\u2013mediated engineering of human intestinal organoids. Nat Med 21:256\u2013262","journal-title":"Nat Med"},{"key":"9878_CR114","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.virol.2018.05.016","volume":"520","author":"AL Mefferd","year":"2018","unstructured":"Mefferd AL, Bogerd HP, Irwan ID, Cullen BR (2018) Insights into the mechanisms underlying the inactivation of HIV-1 proviruses by CRISPR\/Cas. Virology 520:116\u2013126","journal-title":"Virology"},{"issue":"1","key":"9878_CR115","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1365-2958.2000.01838.x","volume":"36","author":"FJ Mojica","year":"2000","unstructured":"Mojica FJ (2000) Biological significance of a family of regularly spaced repeats in the genomes of archaea, Bacteria and mitochondria. Mol Microbiol 36(1):244\u2013246","journal-title":"Mol Microbiol"},{"key":"9878_CR116","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00239-004-0046-3","volume":"60","author":"FJ Mojica","year":"2005","unstructured":"Mojica FJ, D\u00edez-Villase\u00f1or C, Garc\u00eda-Mart\u00ednez J, Soria E (2005) Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol 60:174\u2013182","journal-title":"J Mol Evol"},{"key":"9878_CR117","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/ana.23988","volume":"74","author":"A Nath","year":"2013","unstructured":"Nath A, Tyler KL (2013) Novel approaches and challenges to treatment of central nervous system viral infections. Ann Neurol 74:412\u2013422","journal-title":"Ann Neurol"},{"key":"9878_CR118","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","volume":"351","author":"CE Nelson","year":"2016","unstructured":"Nelson CE, Hakim CH, Ousterout DG, Thakore PI, Moreb EA, Castellanos Rivera RM, Madhavan S, Pan X, Ran FA, Yan WX, Asokan A, Zhang F, Duan D, Gersbach CA (2016) In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science 351:403\u2013407","journal-title":"Science"},{"issue":"3","key":"9878_CR119","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1574-6976.2011.00320.x","volume":"36","author":"MP Nicoll","year":"2012","unstructured":"Nicoll MP, Proen\u00e7a JT, Efstathiou S (2012) The molecular basis of herpes simplex virus latency. FEMS Microbiol Rev 36(3):684\u2013705","journal-title":"FEMS Microbiol Rev"},{"key":"9878_CR120","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature13769","volume":"516","author":"MR O'Connell","year":"2014","unstructured":"O'Connell MR, Oakes BL, Sternberg SH, East-Seletsky A, Kaplan M, Doudna JA (2014) Programmable RNA recognition and cleavage by CRISPR\/Cas9. Nature 516:263\u2013266","journal-title":"Nature"},{"key":"9878_CR121","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.3389\/fmicb.2018.03107","volume":"9","author":"AR Panfil","year":"2018","unstructured":"Panfil AR, London JA, Green PL, Yoder KE (2018) CRISPR\/Cas9 genome editing to disable the latent HIV-1 provirus. Front Microbiol 9:3107. \nhttps:\/\/doi.org\/10.3389\/fmicb.2018.03107","journal-title":"Front Microbiol"},{"issue":"3","key":"9878_CR122","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/sti.2003.005850","volume":"80","author":"R G Pebody","year":"2004","unstructured":"Pebody RG, Andrews N, Brown D, Gopal R, De Melker H, Fran\u00e7ois G, ... Kojouharova M (2004). The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect 80(3): 185\u2013191","journal-title":"Sexually Transmitted Infections"},{"key":"9878_CR123","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","volume":"159","author":"RJ Platt","year":"2014","unstructured":"Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F (2014) CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159:440\u2013455","journal-title":"Cell"},{"key":"9878_CR124","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1099\/mic.0.27437-0","volume":"151","author":"C Pourcel","year":"2005","unstructured":"Pourcel C, Salvignol G, Vergnaud G (2005) CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology 151:653\u2013663","journal-title":"Microbiology"},{"key":"9878_CR125","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1073\/pnas.1422340112","volume":"112","author":"AA Price","year":"2015","unstructured":"Price AA, Sampson TR, Ratner HK, Grakoui A, Weiss DS (2015) Cas9-mediated targeting of viral RNA in eukaryotic cells. Proc Natl Acad Sci U S A 112:6164\u20136169","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9878_CR126","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1534\/genetics.115.176594","volume":"200","author":"W Qin","year":"2015","unstructured":"Qin W, Dion SL, Kutny PM, Zhang Y, Cheng AW, Jillette NL, Malhotra A, Geurts AM, Chen YG, Wang H (2015) Efficient CRISPR\/Cas9-mediated genome editing in mice by zygote electroporation of nuclease. Genetics 200:423\u2013430","journal-title":"Genetics"},{"key":"9878_CR127","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.coviro.2012.07.001","volume":"2","author":"N Raab-Traub","year":"2012","unstructured":"Raab-Traub N (2012) Novel mechanisms of EBV-induced oncogenesis. Curr Opin Virol 2:453\u2013458","journal-title":"Curr Opin Virol"},{"key":"9878_CR128","doi-asserted-by":"publisher","first-page":"42661","DOI":"10.1038\/srep42661","volume":"7","author":"A Raveux","year":"2017","unstructured":"Raveux A, Vandormael-Pournin S, Cohen-Tannoudji M (2017) Optimization of the production of knock-in alleles by CRISPR\/Cas9 microinjection into the mouse zygote. Sci Rep 7:42661. \nhttps:\/\/doi.org\/10.1038\/srep42661","journal-title":"Sci Rep"},{"issue":"11","key":"9878_CR129","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1099\/vir.0.81161-0","volume":"86","author":"MB Reeves","year":"2005","unstructured":"Reeves MB, Lehner PJ, Sissons JGP, Sinclair JH (2005) An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. J Gen Virol 86(11):2949\u20132954","journal-title":"J Gen Virol"},{"key":"9878_CR130","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1086\/500509","volume":"193","author":"MG Revello","year":"2006","unstructured":"Revello MG, Zavattoni M, Furione M, Fabbri E, Gerna G (2006) Preconceptional primary human cytomegalovirus infection and risk of congenital infection. J Infect Dis 193:783\u2013787","journal-title":"J Infect Dis"},{"key":"9878_CR131","doi-asserted-by":"publisher","first-page":"23146","DOI":"10.1038\/srep23146","volume":"6","author":"PC Roehm","year":"2016","unstructured":"Roehm PC, Shekarabi M, Wollebo HS, Bellizzi A, He L, Salkind J, Khalili K (2016) Inhibition of HSV-1 replication by gene editing strategy. Sci Rep 6:23146. \nhttps:\/\/doi.org\/10.1038\/srep23146","journal-title":"Sci Rep"},{"key":"9878_CR132","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/spid.2003.127223","volume":"14","author":"JR Romero","year":"2003","unstructured":"Romero JR, Newland JG (2003) Viral meningitis and encephalitis: traditional and emerging viral agents. Semin Pediatr Infect Dis 14:72\u201382","journal-title":"Semin Pediatr Infect Dis"},{"issue":"Supplement_7","key":"9878_CR133","doi-asserted-by":"crossref","first-page":"S754","DOI":"10.1093\/clinids\/12.Supplement_7.S754","volume":"12","author":"RH Rubin","year":"1990","unstructured":"Rubin RH (1990) Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 12(Supplement_7):S754\u2013S766","journal-title":"Rev Infect Dis"},{"key":"9878_CR134","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jviromet.2014.11.009","volume":"213","author":"TA Russell","year":"2015","unstructured":"Russell TA, Stefanovic T, Tscharke DC (2015) Engineering herpes simplex viruses by infection\u2013transfection methods including recombination site targeting by CRISPR\/Cas9 nucleases. J Virol Methods 213:18\u201325","journal-title":"J Virol Methods"},{"key":"9878_CR135","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1038\/srep05400","volume":"4","author":"T Sakuma","year":"2014","unstructured":"Sakuma T, Nishikawa A, Kume S, Chayama K, Yamamoto T (2014) Multiplex genome engineering in human cells using all-in-one CRISPR\/Cas9 vector system. Sci Rep 4:5400. \nhttps:\/\/doi.org\/10.1038\/srep05400","journal-title":"Sci Rep"},{"key":"9878_CR136","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/gtc.12437","volume":"21","author":"T Sakuma","year":"2016","unstructured":"Sakuma T, Masaki K, Abe-Chayama H, Mochida K, Yamamoto T, Chayama K (2016) Highly multiplexed CRISPR-Cas9-nuclease and Cas9-nickase vectors for inactivation of hepatitis B virus. Genes Cells 21:1253\u20131262","journal-title":"Genes Cells"},{"issue":"2","key":"9878_CR137","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archneur.1996.00550020029012","volume":"53","author":"VJ Sanders","year":"1996","unstructured":"Sanders VJ, Waddell AE, Felisan SL, Li X, Conrad AJ, Tourtellotte WW (1996) Herpes simplex virus in postmortem multiple sclerosis brain tissue. Arch Neurol 53(2):125\u2013133","journal-title":"Arch Neurol"},{"issue":"8","key":"9878_CR138","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/archneur.1997.00550200020005","volume":"54","author":"Virginia J. Sanders","year":"1997","unstructured":"Sanders VJ, Felisan SL, Waddell AE, Conrad AJ, Schmid P, Swartz BE ... Tourtellotte WW (1997) Presence of herpes simplex DNA in surgical tissue from human epileptic seizure foci detected by polymerase chain reaction: preliminary study. Arch Neurol 54(8) 954\u2013960","journal-title":"Archives of Neurology"},{"key":"9878_CR139","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1073\/pnas.1423199113","volume":"113","author":"Y Satou","year":"2016","unstructured":"Satou Y, Miyazato P, Ishihara K, Yaguchi H, Melamed A, Miura M, Fukuda A, Nosaka K, Watanabe T, Rowan AG, Nakao M, Bangham CR (2016) The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome. Proc Natl Acad Sci U S A 113:3054\u20133059","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9878_CR140","doi-asserted-by":"crossref","unstructured":"Savic N, Ringnalda FC, Lindsay H, Berk C, Bargsten K, Li Y ... Jinek M (2018) Covalent linkage of the DNA repair template to the CRISPR-Cas9 nuclease enhances homology-directed repair. Elife 7: e33761","DOI":"10.7554\/eLife.33761.032"},{"issue":"7","key":"9878_CR141","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1128\/JVI.71.7.5423-5431.1997","volume":"71","author":"NM Sawtell","year":"1997","unstructured":"Sawtell NM (1997) Comprehensive quantification of herpes simplex virus latency at the single-cell level. J Virol 71(7):5423\u20135431","journal-title":"J Virol"},{"key":"9878_CR142","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.68","volume":"3","author":"C Seeger","year":"2014","unstructured":"Seeger C, Sohn JA (2014) Targeting hepatitis B virus with CRISPR\/Cas9. Mol Ther-Nucleic Acids 3:e216","journal-title":"Mol Ther-Nucleic Acids"},{"key":"9878_CR143","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelson T, Heckl D, Ebert BL, Root DE, Doench JG, Zhang F (2014) Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343:84\u201387","journal-title":"Science"},{"issue":"3","key":"9878_CR144","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2012.01.014","volume":"36","author":"Liang Shan","year":"2012","unstructured":"Shan L, Deng K, Shroff NS, Durand CM, Rabi SA, Yang HC ... Siliciano RF (2012) Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 36(3): 491\u2013501","journal-title":"Immunity"},{"key":"9878_CR145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1534\/genetics.114.169771","volume":"199","author":"P Singh","year":"2015","unstructured":"Singh P, Schimenti JC, Bolcun-Filas E (2015) A mouse geneticist\u2019s practical guide to CRISPR applications. Genetics 199:1\u201315","journal-title":"Genetics"},{"key":"9878_CR146","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-3-540-77349.8_4","volume":"325","author":"C Sinzger","year":"2008","unstructured":"Sinzger C, Digel M, Jahn G (2008) Cytomegalovirus cell tropism. Curr Top Microbiol Immunol 325:63\u201383. \nhttps:\/\/doi.org\/10.1007\/978-3-540-77349.8_4","journal-title":"Curr Top Microbiol Immunol"},{"key":"9878_CR147","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","volume":"351","author":"IM Slaymaker","year":"2016","unstructured":"Slaymaker IM, Gao L, Zetsche B, Scott DA, Yan WX, Zhang F (2016) Rationally engineered Cas9 nucleases with improved specificity. Science 351:84\u201388","journal-title":"Science"},{"key":"9878_CR148","doi-asserted-by":"crossref","first-page":"8419","DOI":"10.1002\/jcb.27050","volume":"119","author":"J Song","year":"2018","unstructured":"Song J, Zhang X, Ge Q, Yuan C, Chu L, Liang HF, Liao Z, Liu Q, Zhang Z, Zhang B (2018) CRISPR\/Cas9- mediated knockout of HBsAg inhibit proliferation and and tumorigenicity of HBV-positive hepatocellular carcinoma cells. J Cell Biochem 119:8419\u20138431","journal-title":"J Cell Biochem"},{"key":"9878_CR149","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.tim.2017.04.005","volume":"25","author":"JA Soppe","year":"2017","unstructured":"Soppe JA, Lebbink RJ (2017) Antiviral goes viral: harnessing CRISPR\/Cas9 to combat viruses in humans. Trends Microbiol 25:833\u2013850","journal-title":"Trends Microbiol"},{"key":"9878_CR150","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.cell.2012.11.054","volume":"151","author":"M Srivastava","year":"2012","unstructured":"Srivastava M, Nambiar M, Sharma S, Karki SS, Goldsmith G, Hegde M, Kumar S, Pandey M, Singh RK, Ray P, Natarajan R, Kelkar M, De A, Choudhary B, Raghavan SC (2012) An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression. Cell 151:1474\u20131487","journal-title":"Cell"},{"key":"9878_CR151","doi-asserted-by":"publisher","unstructured":"Stern L, Withers B, Avdic S, Gottlieb D, Abendroth A, Blyth E, Slobedman B (2019) Human Cytomegalovirus latency and reactivation in allogeneic hematopoietic stem cell transplant recipients. Front Microbiol. \nhttps:\/\/doi.org\/10.3389\/fmicb.2019.01186","DOI":"10.3389\/fmicb.2019.01186"},{"issue":"6448","key":"9878_CR152","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1126\/science.aax9181","volume":"365","author":"Jonathan Strecker","year":"2019","unstructured":"Strecker J, Ladha A, Gardner Z, Schmid-Burgk JL, Makarova KS, Koonin EV, Zhang F (2019) RNA-guided DNA insertion with CRISPR-associated transposases. Science. \nhttps:\/\/doi.org\/10.1126\/science.aax9181","journal-title":"Science"},{"key":"9878_CR153","doi-asserted-by":"publisher","first-page":"e32724","DOI":"10.7554\/eLife.32724","volume":"7pii","author":"SC Strutt","year":"2018","unstructured":"Strutt SC, Torrez RM, Kaya E, Negrete OA, Doudna JA (2018) RNA-dependent RNA targeting by CRISPR-Cas9. Elife 7pii:e32724. \nhttps:\/\/doi.org\/10.7554\/eLife.32724","journal-title":"Elife"},{"key":"9878_CR154","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nbt.3055","volume":"33","author":"L Swiech","year":"2015","unstructured":"Swiech L, Heidenreich M, Banerjee A, Habib N, Li Y, Trombetta J, Sur M, Zhang F (2015) In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat Biotechnol 33:102\u2013106","journal-title":"Nat Biotechnol"},{"key":"9878_CR155","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","volume":"351","author":"M Tabebordbar","year":"2016","unstructured":"Tabebordbar M, Zhu K, Cheng JKW, Chew WL, Widrick JJ, Yan WX, Maesner C, Wu EY, Xiao R, Ran FA, Cong L, Zhang F, Vandenberghe LH, Church GM, Wagers AJ (2016) In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science 351:407\u2013411","journal-title":"Science"},{"issue":"1","key":"9878_CR156","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/17460441.2017.1255195","volume":"12","author":"L Tang","year":"2017","unstructured":"Tang L, Zhao Q, Wu S, Cheng J, Chang J, Guo JT (2017) The current status and future directions of hepatitis B antiviral drug discovery. Expert Opin Drug Discovery 12(1):5\u201315","journal-title":"Expert Opin Drug Discovery"},{"key":"9878_CR157","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/rmv.710","volume":"22","author":"E Tavazzi","year":"2012","unstructured":"Tavazzi E, White MK, Khalili K (2012) Progressive multifocal leukoencephalopathy: clinical and molecular aspects. Rev Med Virol 22:18\u201332","journal-title":"Rev Med Virol"},{"issue":"7","key":"9878_CR158","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4155\/fmc.10.197","volume":"2","author":"RL Thompson","year":"2010","unstructured":"Thompson RL, Sawtell NM (2010) Therapeutic implications of new insights into the critical role of VP16 in initiating the earliest stages of HSV reactivation from latency. Future Med Chem 2(7):1099\u20131105","journal-title":"Future Med Chem"},{"issue":"9","key":"9878_CR159","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/1087057110379154","volume":"15","author":"S Thompson","year":"2010","unstructured":"Thompson S, Messick T, Schultz DC, Reichman M, Lieberman PM (2010) Development of a high-throughput screen for inhibitors of Epstein-Barr virus EBNA1. J Biomol Screen 15(9):1107\u20131115","journal-title":"J Biomol Screen"},{"key":"9878_CR160","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2015","unstructured":"Tsai SQ, Zheng Z, Nguyen NT, Liebers M, Topkar VV, Thapar V, Wyvekens N, Khayter C, Iafrate AJ, Le LP, Aryee MJ, Joung JK (2015) GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol 33:187\u2013197","journal-title":"Nat Biotechnol"},{"key":"9878_CR161","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/1348-0421.12395","volume":"60","author":"S Ueda","year":"2016","unstructured":"Ueda S, Ebina H, Kanemura Y, Misawa N, Koyanagi Y (2016) Anti-HIV-1 potency of the CRISPR\/Cas9 system insufficient to fully inhibit viral replication. Microbiol Immunol 60:483\u2013496","journal-title":"Microbiol Immunol"},{"key":"9878_CR162","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005701","volume":"12","author":"FR van Diemen","year":"2016","unstructured":"van Diemen FR, Kruse EM, Hooykaas MJ, Bruggeling CE, Sch\u00fcrch AC, van Ham PM, Imhof SM, Nijhuis M, Wiertz EJ, Lebbink RJ (2016) Crispr\/cas9-mediated genome editing of herpesviruses limits productive and latent infections. PLoS Pathog 12:e1005701. \nhttps:\/\/doi.org\/10.1371\/journal.ppat.1005701","journal-title":"PLoS Pathog"},{"key":"9878_CR163","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182974","volume":"12","author":"O Voets","year":"2017","unstructured":"Voets O, Tielen F, Elstak E, Benschop J, Grimbergen M, Stallen J, Janssen R, van Marle A, Essrich C (2017) Highly efficient gene inactivation by adenoviral CRISPR\/Cas9 in human primary cells. PLoS One 12:e0182974. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0182974","journal-title":"PLoS One"},{"key":"9878_CR164","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1111\/febs.13768","volume":"283","author":"S Vora","year":"2016","unstructured":"Vora S, Tuttle M, Cheng J, Church G (2016) Next stop for the CRISPR revolution: RNA-guided epigenetic regulators. FEBS J 283:3181\u20133193","journal-title":"FEBS J"},{"key":"9878_CR165","volume-title":"Human herpesviruses: biology, therapy, and Immunoprophylaxis","author":"A Wald","year":"2007","unstructured":"Wald A, Corey L (2007) Persistence in the population: epidemiology, transmission. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (eds) Human herpesviruses: biology, therapy, and Immunoprophylaxis. Cambridge University Press, Cambridge Chapter 36"},{"key":"9878_CR166","doi-asserted-by":"crossref","first-page":"13157","DOI":"10.1073\/pnas.1410785111","volume":"111","author":"J Wang","year":"2014","unstructured":"Wang J, Quake SR (2014) Rna-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection. Proc Natl Acad Sci U S A 111:13157\u201313162","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9878_CR167","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.cell.2013.04.025","volume":"153","author":"H Wang","year":"2013","unstructured":"Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R (2013) One-step generation of mice carrying mutations in multiple genes by CRISPR\/Cas-mediated genome engineering. Cell 153:910\u2013918","journal-title":"Cell"},{"key":"9878_CR168","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115987","volume":"9","author":"W Wang","year":"2014","unstructured":"Wang W, Ye C, Liu J, Zhang D, Kimata JT, Zhou P (2014) CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection. PLoS One 9:e115987. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0115987","journal-title":"PLoS One"},{"key":"9878_CR169","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/j.celrep.2016.11.057","volume":"17","author":"G Wang","year":"2016","unstructured":"Wang G, Zhao N, Berkhout B, Das AT (2016a) A combinatorial CRISPR Cas9 attack on HIV-1 DNA extinguishes all infectious provirus in infected T cell cultures. Cell Rep 17:2819\u20132826","journal-title":"Cell Rep"},{"key":"9878_CR170","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/mt.2016.24","volume":"24","author":"G Wang","year":"2016","unstructured":"Wang G, Zhao N, Berkhout B, Das AT (2016b) CRISPR-Cas9 can inhibit HIV-1 replication but NHEJ repair facilitates virus escape. Mol Ther 24:522\u2013526","journal-title":"Mol Ther"},{"key":"9878_CR171","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1073\/pnas.1520244113","volume":"113","author":"M Wang","year":"2016","unstructured":"Wang M, Zuris JA, Meng F, Rees H, Sun S, Deng P, Han Y, Gao X, Pouli D, Wu Q, Georgakoudi I, Liu DR, Xu Q (2016c) Efficient delivery of genome editing proteins using bioreducible lipid nanoparticles. Proc Natl Acad Sci U S A 113:2868\u20132873","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9878_CR172","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.virusres.2017.07.020","volume":"244","author":"G Wang","year":"2018","unstructured":"Wang G, Zhao N, Berkhout B, Das AT (2018a) CRISPR-Cas based antiviral strategies against HIV-1. Virus Res 244:321\u2013332","journal-title":"Virus Res"},{"key":"9878_CR173","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13059-018-1445-x","volume":"19","author":"Y Wang","year":"2018","unstructured":"Wang Y, Liu KI, Sutrisnoh NB, Srinivasan H, Zhang J, Li J, Zhang F, Lalith CRJ, Xing H, Shanmugam R, Foo JN, Yeo HT, Ooi KH, Bleckwehl T, Par YYR, Lee SM, Ismail NNB, Sanwari NAB, Lee STV, Lew J, Tan MH (2018b) Systematic evaluation of CRISPR-Cas systems reveals design principles for genome editing in human cells. Genome Biol 19:62. \nhttps:\/\/doi.org\/10.1186\/s13059-018-1445-x","journal-title":"Genome Biol"},{"key":"9878_CR174","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/COH.0000000000000484","volume":"13","author":"Y Wen","year":"2018","unstructured":"Wen Y, Bar KJ, Li JZ (2018) Lessons learned from HIV antiretroviral treatment interruption trials. Curr Opin HIV AIDS 13:416\u2013421","journal-title":"Curr Opin HIV AIDS"},{"issue":"5","key":"9878_CR175","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/infdis\/jiq097","volume":"203","author":"MK White","year":"2011","unstructured":"White MK, Khalili K (2011) Pathogenesis of progressive multifocal leukoencephalopathy\u2014revisited. J Infect Dis 203(5):578\u2013586","journal-title":"J Infect Dis"},{"issue":"3","key":"9878_CR176","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003206","volume":"9","author":"MK White","year":"2013","unstructured":"White MK, Gordon J, Khalili K (2013) The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology. PLoS Pathog 9(3):e1003206","journal-title":"PLoS Pathog"},{"key":"9878_CR177","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s13311-016-0439-1","volume":"13","author":"MK White","year":"2016","unstructured":"White MK, Kaminski R, Wollebo H, Hu W, Malcolm T, Khalili K (2016) Gene editing for treatment of neurological infections. Neurotherapeutics 13:547\u2013554","journal-title":"Neurotherapeutics"},{"issue":"9","key":"9878_CR178","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1128\/JVI.03505-12","volume":"87","author":"CB Whitehurst","year":"2013","unstructured":"Whitehurst CB, Sanders MK, Law M, Wang FZ, Xiong J, Dittmer DP, Pagano JS (2013) Maribavir inhibits Epstein-Barr virus transcription through the EBV protein kinase. J Virol 87(9):5311\u20135315","journal-title":"J Virol"},{"key":"9878_CR179","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","volume":"357","author":"RJ Whitley","year":"2001","unstructured":"Whitley RJ, Roizman B (2001) Herpes simplex virus infections. Lancet 357:1513\u20131518","journal-title":"Lancet"},{"issue":"7385","key":"9878_CR180","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nature10886","volume":"482","author":"B Wiedenheft","year":"2012","unstructured":"Wiedenheft B, Sternberg SH, Doudna JA (2012) RNA-guided genetic silencing systems in bacteria and archaea. Nature 482(7385):331","journal-title":"Nature"},{"issue":"11","key":"9878_CR181","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1086\/656721","volume":"202","author":"Fiona Wightman","year":"2010","unstructured":"Wightman F, Solomon A, Khoury G, Green JA, Gray L, Gorry PR ... Cameron PU (2010). Both CD31+ and CD31-naive CD4+ T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy. J Infect Dis 202(11): 1738\u20131748","journal-title":"The Journal of Infectious Diseases"},{"issue":"9","key":"9878_CR182","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136046","volume":"10","author":"HS Wollebo","year":"2015","unstructured":"Wollebo HS, Bellizzi A, Kaminiski R, Hu W, White MK, Khalili K (2015a) Crisper\/Cas9 system as an agent for eliminating polyomavirus JC infection. PLoS One 10(9):e0136046. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0136046","journal-title":"PLoS One"},{"key":"9878_CR183","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.24371","volume":"77","author":"HS Wollebo","year":"2015","unstructured":"Wollebo HS, White MK, Gordon J, Berger JR, Khalili K (2015b) Persistence and pathogenesis of the neurotropic polyomavirus JC. Ann Neurol 77:560\u2013570","journal-title":"Ann Neurol"},{"key":"9878_CR184","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40484-014-0030-x","volume":"2","author":"X Wu","year":"2014","unstructured":"Wu X, Kriz AJ, Sharp PA (2014) Target specificity of the CRISPR-Cas9 system. Quant Biol 2:59\u201370","journal-title":"Quant Biol"},{"issue":"8","key":"9878_CR185","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1086\/340041","volume":"185","author":"F Xu","year":"2002","unstructured":"Xu F, Schillinger JA, Sternberg MR, Johnson RE, Lee FK, Nahmias AJ, Markowitz LE (2002) Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988\u20131994. J Infect Dis 185(8):1019\u20131024","journal-title":"J Infect Dis"},{"key":"9878_CR186","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12985-016-0600-9","volume":"13","author":"X Xu","year":"2016","unstructured":"Xu X, Fan S, Zhou J, Zhang Y, Che Y, Cai H, Wang L, Guo L, Liu L, Li Q (2016) The mutated tegument protein U17 attenuates the virulence of herpes simplex virus 1 by reducing the modulation of alpha-4 gene transcription. Virol J 13:152. \nhttps:\/\/doi.org\/10.1186\/s12985-016-0600-9","journal-title":"Virol J"},{"key":"9878_CR187","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.cell.2016.04.003","volume":"165","author":"T Yamano","year":"2016","unstructured":"Yamano T, Nishimasu H, Zetsche B, Hirano H, Slaymaker IM, Li Y, Fedorova I, Nakane T, Makarova KS, Koonin EV, Ishitani R, Zhang F, Nureki O (2016) Crystal structure of Cpf1 in complex with guide RNA and target DNA. Cell 165:949\u2013962","journal-title":"Cell"},{"key":"9878_CR188","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.aav7271","volume":"363","author":"WX Yan","year":"2019","unstructured":"Yan WX, Hunnewell P, Alfonse LE, Carte JM, Keston-Smith E, Sothiselvam S, Garrity AJ, Chong S, Makarova KS, Koonin EV, Cheng DR, Scott DA (2019) Functionally diverse type V CRISPR-Cas systems. Science 363:88\u201391","journal-title":"Science"},{"key":"9878_CR189","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.virusres.2017.06.010","volume":"244","author":"HC Yang","year":"2018","unstructured":"Yang HC, Chen PJ (2018) The potential and challenges of CRISPR-Cas9 in eradication of hepatisis B virus covalently closed circular DNA. Virus Res 244:304\u2013310","journal-title":"Virus Res"},{"key":"9878_CR190","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2015.067","volume":"26","author":"S Yao","year":"2015","unstructured":"Yao S, He Z, Chen C (2015) CRISPR\/Cas9-mediated genome editing of epigenetic factors for cancer therapy. Hum Gene Ther 26:463\u2013471","journal-title":"Hum Gene Ther"},{"key":"9878_CR191","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nbt.3471","volume":"34","author":"H Yin","year":"2016","unstructured":"Yin H, Song CQ, Dorkin JR, Zhu LJ, Li Y, Wu Q, Park A, Yang J, Suresh S, Bizhanova A, Gupta A, Bolukbasi MF, Walsh S, Bogorad RL, Gao G, Weng Z, Dong Y, Koteliansky V, Wolfe SA, Langer R, Xue W, Anderson DG (2016) Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nat Biotechnol 34:328\u2013333","journal-title":"Nat Biotechnol"},{"issue":"5","key":"9878_CR192","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.ymthe.2017.03.012","volume":"25","author":"C Yin","year":"2017","unstructured":"Yin C, Zhang T, Qu X, Zhang Y, Putatunda R, Xiao X et al (2017) In vivo excision of HIV-1 provirus by saCas9 and multiplex single-guide RNAs in animal models. Mol Ther 25(5):1168\u20131186","journal-title":"Mol Ther"},{"key":"9878_CR193","doi-asserted-by":"publisher","first-page":"29530","DOI":"10.1038\/srep29530","volume":"6","author":"KE Yoder","year":"2016","unstructured":"Yoder KE, Bundschuh R (2016) Host double strand break repair generates HIV-1 strains resistant to CRISPR\/Cas9. Sci Rep 6:29530. \nhttps:\/\/doi.org\/10.1038\/srep29530","journal-title":"Sci Rep"},{"key":"9878_CR194","first-page":"2197","volume":"17","author":"T Yoshiba","year":"2019","unstructured":"Yoshiba T, Saga Y, Urabe M, Uchibori R, Matsubara S, Fujiwara H, Mizukami H (2019) CRISPR\/Cas9-mediated cervical cancer treatment targeting human papillomavirus E6. Oncol Lett 17:2197\u20132206","journal-title":"Oncol Lett"},{"key":"9878_CR195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-4939-6472-7_2","volume":"1498","author":"KS Yuen","year":"2017","unstructured":"Yuen KS, Chan CP, Kok KH, Jin DY (2017) Mutagenesis and genome engineering of Epstein\u2013Barr virus in cultured human cells by CRISPR\/Cas9. Methods Mol Biol 1498:23\u201331","journal-title":"Methods Mol Biol"},{"key":"9878_CR196","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.virusres.2017.04.019","volume":"244","author":"KS Yuen","year":"2018","unstructured":"Yuen KS, Wang ZM, Wong NHM, Zhang ZQ, Cheng TF, Lui WY et al (2018a) Suppression of Epstein-Barr virus DNA load in latently infected nasopharyngeal carcinoma cells by CRISPR\/Cas9. Virus Res 244:296\u2013303","journal-title":"Virus Res"},{"key":"9878_CR197","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.virusres.2017.04.019","volume":"244","author":"KS Yuen","year":"2018","unstructured":"Yuen KS, Wang ZM, Wong NM, Zhang ZQ, Cheng TF, Lui WY, Chan CP, Jin DY (2018b) Suppression of Epstein-Barr virus DNA load in latently infected nasopharyngeal carcinoma cells by CRISPR\/Cas9. Virus Res 244:296\u2013303","journal-title":"Virus Res"},{"key":"9878_CR198","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.3389\/fpls.2016.01673","volume":"7","author":"SS Zaidi","year":"2016","unstructured":"Zaidi SS, Tashkandi M, Mansoor S, Mahfouz MM (2016) Engineering plant immunity: using CRISPR\/Cas9 to generate virus resistance. Front Plant Sci 7:1673. \nhttps:\/\/doi.org\/10.3389\/fpls.2016.01673","journal-title":"Front Plant Sci"},{"key":"9878_CR199","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","volume":"163","author":"B Zetsche","year":"2015","unstructured":"Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P, Volz SE, Joung J, van der Oost J, Regev A, Koonin EV, Zhang F (2015) Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163:759\u2013771","journal-title":"Cell"},{"key":"9878_CR200","doi-asserted-by":"crossref","first-page":"16277","DOI":"10.1038\/srep16277","volume":"5","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Yin C, Zhang T, Li F, Yang W, Kaminski R, Hu W (2015) CRISPR\/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs. Sci Rep 5:16277","journal-title":"Sci Rep"},{"key":"9878_CR201","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jgg.2016.03.001","volume":"43","author":"D Zhang","year":"2016","unstructured":"Zhang D, Li Z, Li JF (2016) Targeted gene manipulation in plants using the CRISPR\/Cas technology. J Genet Genomics 43:251\u2013262","journal-title":"J Genet Genomics"},{"key":"9878_CR202","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1159\/000486168","volume":"44","author":"S Zhen","year":"2017","unstructured":"Zhen S, Li X (2017) Oncogenic human papillomavirus: application of CRISPR\/Cas9 therapeutic strategies for cervical cancer. Cell Physiol Biochem 44:2455\u20132466","journal-title":"Cell Physiol Biochem"},{"key":"9878_CR203","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/gt.2015.2","volume":"22","author":"S Zhen","year":"2015","unstructured":"Zhen S, Hua L, Liu YH, Gao LC, Fu J, Wan DY, Dong LH, Song HF, Gao X (2015) Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)\/CRISPR-associated Cas9 system to disrupt the hepatitis B virus. Gene Ther 22:404\u2013412","journal-title":"Gene Ther"},{"key":"9878_CR204","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.tranon.2016.10.002","volume":"9","author":"S Zhen","year":"2016","unstructured":"Zhen S, Lu JJ, Wang LJ, Sun XM, Zhang JQ, Li X, Luo WJ, Zhao L (2016) In vitro and in vivo synergistic therapeutic effect of cisplatin with human papillomavirus 16 E6\/E7 CRISPR\/Cas9 on cervical Cancer cell line. Transl Oncol 9:498\u2013504","journal-title":"Transl Oncol"},{"key":"9878_CR205","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12977-015-0150-z","volume":"12","author":"W Zhu","year":"2015","unstructured":"Zhu W, Lei R, Le Duff Y, Li J, Guo F, Wainberg MA, Liang C (2015) The CRISPR\/Cas9 system inactivates latent HIV-1 proviral DNA. Retrovirology 12:22. \nhttps:\/\/doi.org\/10.1186\/s12977-015-0150-z","journal-title":"Retrovirology"},{"key":"9878_CR206","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41564-018-0131-9","volume":"3","author":"D Zhu","year":"2018","unstructured":"Zhu D, Pan C, Sheng J, Liang H, Bian Z, Liu Y (2018) Human cytomegalovirus reprograms haematopoietic progenitor cells into immunosuppressive monocytes to achieve latency. Nat Microbiol 3:503\u2013513. \nhttps:\/\/doi.org\/10.1038\/s41564-018-0131-9","journal-title":"Nat Microbiol"},{"key":"9878_CR207","doi-asserted-by":"publisher","first-page":"7391","DOI":"10.1038\/ncomms8391","volume":"6","author":"M Zuckermann","year":"2015","unstructured":"Zuckermann M, Hovestadt V, Knobbe-Thomsen CB, Zapatka M, Northcott PA, Schramm K, Belic J, Jones DT, Tschida B, Moriarity B, Largaespada D, Roussel MF, Korshunov A, Reifenberger G, Pfister SM, Lichter P, Kawauchi D, Gronych J (2015) Somatic CRISPR\/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling. Nat Commun 6:7391. \nhttps:\/\/doi.org\/10.1038\/ncomms8391","journal-title":"Nat Commun"},{"key":"9878_CR208","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt.3081","volume":"33","author":"JA Zuris","year":"2015","unstructured":"Zuris JA, Thompson DB, Shu Y, Guilinger JP, Bessen JL, Hu JH, Maeder ML, Joung JK, Chen ZY, Liu DR (2015) Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat Biotechnol 33:73\u201380","journal-title":"Nat Biotechnol"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-019-09878-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-019-09878-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-019-09878-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T18:47:58Z","timestamp":1599763678000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-019-09878-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,11]]},"references-count":208,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9878"],"URL":"https:\/\/doi.org\/10.1007\/s11481-019-09878-7","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,11]]},"assertion":[{"value":"3 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}